BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Endothelial cell
,
Holistic medicine
,
Vitamin E
,
rs2230926
,
PDX1
,
Lung cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
radiosensitizing agents
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
CDKN1A
ATF3
FOS
CXCL8
GDF15
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
heterocyclic compound binding
organic cyclic compound binding
cytosol
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
organic cyclic compound metabolic process
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Lungs and livers of mice exposed to nano-titanium dioxide particles by inhalation
Response to cisplatin in tumorigenic and non-tumorigenic cell lines
Jejunum gene expression in irinotecan-treated rats 6 and 72hr post injection
A549 lung adenocarcinoma cell expression profiling in response to the telomerase inhibitor TMPyP4
Colon tumor gene expression profiling before and after acquired resistance to gemcitabine
Explore Curated Studies Results
Literature
Most Relevant Literature
Intensity-modulated radiation therapy with hypoxic sensitizer AK-2123 (sanazole) for glioblastoma mu…
Current status of radiosensitizing agents for the management of rectal cancer.
Electron paramagnetic resonance highlights that the oxygen effect contributes to the radiosensitizin…
Radiosensitizing effect of 5-aminolevulinic acid-induced protoporphyrin IX in glioma cells in vitro.
Cell killing and radiosensitizing effects of atorvastatin in PC3 prostate cancer cells.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma
Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer
Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Tri…
A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fi…
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ